Who are we?
Who are we?
The BWB stands for “Biothèque Wallonie Bruxelles”, the university biobank federation for Brussels and Wallonia. As a partnership between 3 major french speaking universities in order to foster translational research in biomedical science, the BWB provides acces to biological samples from human origin kept by the university biobanks and their partners. The project fits into the BBMRI.eu initiative and benefits from support from public authorities (Innoviris for the Brussels capital region and DG06 for the Walloon region).
What's the BWB?
The BWB offers an interface between tissues and cells collections (biospecimens) from human origin that are kept and managed by universities and university hospitals and the needs of the researchers. It presents a virtual catalogue of those collections.
BWB and its partners help researchers to gain access to the biospecimens required in their biomedical research projects. BWB is born from the collaboration of 3 universities (UCL, ULB and ULg) and their university hospitals aiming at virtually integrating their respective biobanks. They benefit from the support of the regional government from Brussels (Innoviris) and Wallonia (DG06) in order to consolidate their forces and take part to the BBMRI network.
What do we do?
The BWB manages the virtual catalog of samples kept by the participating biobanks. Researches can access it to find easily where the needed biospecimens can be found. The BWB brings them also in contact with the biobank managers in order to facilitate the supply of the requirement material. The BWB and its partners can also help to find an appropriate solution for requests that cannot be satisfied within existing collections. The BWB ensures as well that the necessary approval has been obtained by the Ethical Committee.
Why? Who benefits?
No medicine nor in-vitro diagnostic can be released without having satisfied a complete test procedure. One step consists of pre-clinical test on cells and tissues of human origin. The development won’t go further prior this phase having been successfully passed. Easy access to biospecimens strengthens the reliability of those tests.